Adjusting forecast for the current fiscal year

Bremen, September 4, 2024 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its annual forecast for the current fiscal year based on the preliminary business figures for the first eleven months.

• For fiscal year 2023/2024 (October 1, 2023 to September 30, 2024), sales are now expected to remain stable at between € 17.0 million and € 17.5 million (previous forecast for fiscal year 2023/2024: slight increase in sales from € 18.0 million to € 18.5 million).
• EBIT (earnings before interest and taxes) is now expected to fall to between € 3.0 million and € 3.5 million in fiscal year 2023/2024 (October 1, 2023 to September 30, 2024) (previous forecast for fiscal year 2023/2024: stability in the range of € 4.5 million to € 5.0 million).

The reasons for the decline in sales are an unexpected cautiousness in purchasing behavior due to global economic challenges. In addition, the result will be strongly impacted by the development of the US dollar/euro exchange rate since the beginning of the fiscal year.

************************************************************************